Side-by-side comparison
Abbott Laboratories vs Becton, Dickinson and
As of Sep 25, 2026, P/E is 28.4x for Abbott Laboratories vs 55.5x for Becton, Dickinson and; P/S is 3.9x for Abbott Laboratories vs 2.2x for Becton, Dickinson and; revenue growth is 6.6% for Abbott Laboratories vs 18.5% for Becton, Dickinson and; operating margin is 17.1% for Abbott Laboratories vs 10.7% for Becton, Dickinson and.
Key metrics
| Metric | ABT | BDX |
|---|---|---|
| Price | $101.29 | $183.82 |
| Market cap | $176.43B | $50.07B |
| P/E | 28.4x (#1) | 55.5x (#2) |
| P/S | 3.9x (#2) | 2.2x (#1) |
| Revenue growth | 6.6% (#2) | 18.5% (#1) |
| Operating margin | 17.1% (#1) | 10.7% (#2) |
| Net margin | 13.9% (#1) | 4.2% (#2) |
| Debt / equity | 0.57 (#2) | 0.55 (#1) |
| 1-year return | -24.2% (#2) | +26.7% (#1) |
| Research score | 48/100 (#2) | 53/100 (#1) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Abbott Laboratories (ABT) — Medical Devices
- Becton, Dickinson and Company (BDX) — Medical Instruments & Supplies